Product Information
ALFUZOSIN HCL ER 10 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1074 per EA under NDC 69097084407. Its NADAC has been published 464 times since Oct 12, 2016.
Strength
10 mg/1
Manufacturer
Cipla USA Inc.NDC
69097084407
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
ALFUZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090284On Market Since
6/30/2016
Pharmacological Classes
Price Statistics
The NADAC for ALFUZOSIN HCL ER 10 MG TABLET has been published 464 times since Oct 12, 2016, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1074 per EA |
|---|---|
| All-time high | $0.1922 (Nov 16, 2016) |
| All-time low | $0.1034 (Jan 22, 2025) |
| 52-week high | $0.1090 |
| 52-week low | $0.1052 |
| Median price | $0.1323 |
| Average price | $0.1350 |
| Largest weekly change | +32.0% (Nov 22, 2023) |
| Weeks tracked | 464 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALFUZOSIN HCL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALFUZOSIN HCL ER 10 MG TABLET, manufactured by Cipla USA Inc., is $0.1074 per EA (NDC 69097084407), effective Feb 18, 2026.
How has the price of ALFUZOSIN HCL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has declined 42.1%. It has been tracked across 464 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for ALFUZOSIN HCL ER 10 MG TABLET?
Since Oct 12, 2016, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has ranged from a low of $0.1034 (Jan 22, 2025) to a high of $0.1922 (Nov 16, 2016), with a median of $0.1323 per EA.
Are there cheaper alternatives to ALFUZOSIN HCL ER 10 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as ALFUZOSIN HCL ER 10 MG TABLET, but none are currently priced below it.
Who manufactures ALFUZOSIN HCL ER 10 MG TABLET?
ALFUZOSIN HCL ER 10 MG TABLET (NDC 69097084407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification